Pharmaceuticals

Various EU products and services began to enjoy benefits from the EU-Japan Economic Partnership Agreement (EPA) which entered in force on 1 February 2019, and we are seeing a considerable increase of EU exports to Japan. But yet many EU exporters, particularly small and medium-scaled enterprises (SMEs) perceive access to Japanese market difficult because of unfamiliar trade and business practices.

What should you know when entering Pharmaceutical market in Japan?

Various EU products and services began to enjoy benefits from the EU-Japan Economic Partnership Agreement (EPA) which entered in force on 1 February 2019, and we are seeing a considerable increase of EU exports to Japan.  But yet many EU exporters, particularly small and medium-scaled enterprises (SMEs) perceive access to Japanese market difficult because of unfamiliar trade and business practices.

About the Report: 

How can I access the Japanese market as a novel biopharmaceutical product's owner?

About the Report 

What business opportunities currently exist for European SMEs seeking to invest in Japanese markets for pharmaceutical products and services?

Which opportunities does the Biopharmaceutical market in Japan offer to EU companies?

PR euroCHEM / SME / Search for Partners in Japan

Founded in 1998 in Ireland, PR euroCHEM is dedicated to the provision of R&D and organic synthesis services to the Fine Chemicals and Pharmachem Industries.

BioJapan is Asia’s premier partnering event for the international biotechnology industry. This event facilitates interaction between biotech executives, R&D professionals, alliance management personnel and licensing professionals from Japan and overseas. The event is attended by almost all Japanese biotech and pharmaceutical companies. BioJapan also offers a partnering programme which allows attendees to set up meetings with one another prior to the event. The fair is held in October every year.